0001752445-23-000001.txt : 20230310 0001752445-23-000001.hdr.sgml : 20230310 20230310164130 ACCESSION NUMBER: 0001752445-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230310 DATE AS OF CHANGE: 20230310 EFFECTIVENESS DATE: 20230310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SEngine Precision Medicine, Inc. CENTRAL INDEX KEY: 0001752445 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-475546 FILM NUMBER: 23724291 BUSINESS ADDRESS: STREET 1: 401 TERRY AVE N. CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-732-2165 MAIL ADDRESS: STREET 1: 401 TERRY AVE N. CITY: SEATTLE STATE: WA ZIP: 98109 D 1 primary_doc.xml X0708 D LIVE 0001752445 SEngine Precision Medicine, Inc. 401 TERRY AVE N. SEATTLE WA WASHINGTON 98109 206-732-2165 DELAWARE None None Corporation true Carla Grandori 401 Terry Ave N. Seattle WA WASHINGTON 98109 Executive Officer Director Promoter Tony Hsu 401 Terry Ave N. Seattle WA WASHINGTON 98109 Executive Officer Pablo Prichard 401 Terry Ave N. Seattle WA WASHINGTON 98109 Director Elliott Burkland 401 Terry Ave N. Seattle WA WASHINGTON 98109 Director Christopher Kemp 401 Terry Ave N. Seatttle WA WASHINGTON 98109 Executive Officer Promoter Biotechnology Decline to Disclose 06b false 2023-02-24 false true true true false 0 3577538 600000 2977538 In addition to the issuance of convertible promissory notes, the Company issued warrants to purchase common stock. The consideration for the warrants, if any, will only be realized upon exercise of the warrants. false 2 0 0 0 false SEngine Precision Medicine, Inc. /s/ Carla Grandori Carla Grandori President and CEO 2023-03-10